These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 33794332)

  • 1. Mitochondria: The metabolic switch of cellular oncogenic transformation.
    Tan YQ; Zhang X; Zhang S; Zhu T; Garg M; Lobie PE; Pandey V
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188534. PubMed ID: 33794332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria and Cancer.
    Zong WX; Rabinowitz JD; White E
    Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer.
    Yi HS; Chang JY; Kim KS; Shong M
    Korean J Intern Med; 2017 Sep; 32(5):780-789. PubMed ID: 28823142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial ROS control of cancer.
    Idelchik MDPS; Begley U; Begley TJ; Melendez JA
    Semin Cancer Biol; 2017 Dec; 47():57-66. PubMed ID: 28445781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
    Bellot GL; Liu D; Pervaiz S
    Mitochondrion; 2013 May; 13(3):155-62. PubMed ID: 22750269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncogenic role of HBXIP.
    Xiu M; Zeng X; Shan R; Wen W; Li J; Wan R
    Biomed Pharmacother; 2021 Jan; 133():111045. PubMed ID: 33378953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial determinants of cancer health disparities.
    Choudhury AR; Singh KK
    Semin Cancer Biol; 2017 Dec; 47():125-146. PubMed ID: 28487205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming Oxidative Phosphorylation in Cancer: A Role for RNA-Binding Proteins.
    Esparza-Moltó PB; Cuezva JM
    Antioxid Redox Signal; 2020 Nov; 33(13):927-945. PubMed ID: 31910046
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitochondrial Tumor Suppressors-The Energetic Enemies of Tumor Progression.
    Jakoube P; Cutano V; González-Morena JM; Keckesova Z
    Cancer Res; 2021 Sep; 81(18):4652-4667. PubMed ID: 34183354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated metabolism contributes to oncogenesis.
    Hirschey MD; DeBerardinis RJ; Diehl AME; Drew JE; Frezza C; Green MF; Jones LW; Ko YH; Le A; Lea MA; Locasale JW; Longo VD; Lyssiotis CA; McDonnell E; Mehrmohamadi M; Michelotti G; Muralidhar V; Murphy MP; Pedersen PL; Poore B; Raffaghello L; Rathmell JC; Sivanand S; Vander Heiden MG; Wellen KE;
    Semin Cancer Biol; 2015 Dec; 35 Suppl():S129-S150. PubMed ID: 26454069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of compartmentalized signaling pathways in the control of mitochondrial activities in cancer cells.
    Rinaldi L; Delle Donne R; Borzacchiello D; Insabato L; Feliciello A
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):293-302. PubMed ID: 29673970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To betray or to fight? The dual identity of the mitochondria in cancer.
    Zhang X; Su Q; Zhou J; Yang Z; Liu Z; Ji L; Gao H; Jiang G
    Future Oncol; 2021 Feb; 17(6):723-743. PubMed ID: 33459048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAS-mediated oncogenic signaling pathways in human malignancies.
    Khan AQ; Kuttikrishnan S; Siveen KS; Prabhu KS; Shanmugakonar M; Al-Naemi HA; Haris M; Dermime S; Uddin S
    Semin Cancer Biol; 2019 Feb; 54():1-13. PubMed ID: 29524560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Synthetic Lethal Interaction between Glutathione Synthesis and Mitochondrial Reactive Oxygen Species Provides a Tumor-Specific Vulnerability Dependent on STAT3.
    Garama DJ; Harris TJ; White CL; Rossello FJ; Abdul-Hay M; Gough DJ; Levy DE
    Mol Cell Biol; 2015 Nov; 35(21):3646-56. PubMed ID: 26283727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learning from oncocytic tumors: Why choose inefficient mitochondria?
    Gasparre G; Romeo G; Rugolo M; Porcelli AM
    Biochim Biophys Acta; 2011 Jun; 1807(6):633-42. PubMed ID: 20732299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism.
    Rogalinska M
    Mini Rev Med Chem; 2016; 16(7):524-30. PubMed ID: 26471969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target.
    Infantino V; Santarsiero A; Convertini P; Todisco S; Iacobazzi V
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.